REG - Eden Research plc - AIM Rule 17 Notification

Eden ResearchAnnouncement

24/10/2022 12:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221024:nRSX8925Da&default-theme=true

RNS Number : 8925D  Eden Research plc  24 October 2022

24 October 2022

 

Eden Research Plc

("Eden" or the "Company")

AIM Rule 17 Notification

Eden Research Plc (AIM: EDEN) the AIM-quoted company focused on sustainable
biopesticides and plastic-free formulation technology for use in the global
crop protection, animal health and consumer products industries, announces the
following additional director disclosure provided pursuant to AIM Rule 17 and
Schedule 2(g) of the AIM Rules.

Richard Horsman, Non-executive director of Eden, is Non-executive chairman of
Toople Plc ("Toople"). On 21 October 2022, the Directors of Toople appointed
an administrator to preserve value for creditors.

 

For further information contact:

 

 Eden Research plc                                     www.edenresearch.com (http://www.edenresearch.com/)
 Sean Smith                                            01285 359 555

Alex Abrey

 Cenkos Securities plc (Nominated advisor and broker)
 Giles Balleny / Max Gould (corporate finance)         020 7397 8900

Michael Johnson (sales)

 Hawthorn Advisors (Financial PR)
 Victoria Ainsworth                                    eden@hawthornadvisors.com (mailto:eden@hawthornadvisors.com)

Stephen Atkinson

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNUSARRUUURUAA